Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Molecules (Basel, Switzerland)|November 27, 2025
Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes MellitusZia Shariat-Madar, Fakhri MahdiCardiology in Review|April 9, 2015
Plasma Kallikrein Inhibitors in Cardiovascular Disease: An Innovative Therapeutic ApproachDhaval Kolte, Zia Shariat-MadarJournal of Endotoxin Research|March 18, 2004
The plasma kallikrein/kinin and renin angiotensin systems in blood pressure regulation in sepsisZia Shariat-Madar, Alvin H SchmaierBiomolecules|March 28, 2025
Distinct Roles of Common Genetic Variants and Their Contributions to Diabetes: MODY and Uncontrolled T2DMShadi Bazzazzadehgan, Zia Shariat-Madar, Fakhri MahdiCardiovascular & Hematological Agents in Medicinal Chemistry|December 31, 2016
Altered Prolylcarboxypeptidase Expression and Function in Response to Different Risk Factors of DiabetesTahmineh Tabrizian, Lillie Floyd, Zia Shariat-MadarThe Journal of Biological Chemistry|February 7, 2002
Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activatorZia Shariat-Madar, Fakhri Mahdi, Alvin H SchmaierThe Journal of Biological Chemistry|August 29, 2003
The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cellsFakhri Mahdi, Zia Shariat-Madar, Alvin H SchmaierInternational Immunopharmacology|December 20, 2002
Assembly and activation of the plasma kallikrein/kinin system: a new interpretationZia Shariat-Madar, Fakhri Mahdi, Alvin H SchmaierCurrent Molecular Medicine|November 21, 2019
Dynorphins in Development and Disease: Implications for Cardiovascular DiseaseCody Cissom, Jason J Paris, Zia Shariat-MadarBlood|March 5, 2004
Recombinant prolylcarboxypeptidase activates plasma prekallikreinZia Shariat-Madar, Fakhri Mahdi, Alvin H SchmaierPageof 4